Scarica l'app Stockscreener
4.1499
5.36%
0.2049
Nrx Pharmaceuticals Inc Borsa (NRXP) Ultime notizie
Enterprise value to revenue forward of NRX Pharmaceuticals, Inc. – NASDAQ:NRXP - TradingView
NRXP Should I Buy - Intellectia AI
First Patients Treated via FDA-Cleared Transcranial Magnetic Stimulation, Plus FDA Grant on D-Cycloserine-Based Drug for Depression: NRx Pharmaceuticals, Inc. (Nasdaq: NRXP) - Barchart.com
NRx Pharmaceuticals, Inc.(NasdaqCM:NRXP) dropped from Russell 3000E Growth Benchmark - marketscreener.com
NRx Pharmaceuticals, Inc.(NasdaqCM:NRXP) dropped from Russell Microcap Growth Benchmark Index - marketscreener.com
Price to book forward of NRX Pharmaceuticals, Inc. – NASDAQ:NRXP - TradingView
Price to book forward of NRX Pharmaceuticals, Inc. – DUS:B1Q - TradingView
Price to sales forward of NRX Pharmaceuticals, Inc. – NASDAQ:NRXP - TradingView
Enterprise value to revenue forward of NRX Pharmaceuticals, Inc. – DUS:B1Q - TradingView
Price to sales forward of NRX Pharmaceuticals, Inc. – DUS:B1Q - TradingView
Enterprise value to EBITDA forward of NRX Pharmaceuticals, Inc. – NASDAQ:NRXP - TradingView
Price to earnings forward of NRX Pharmaceuticals, Inc. – NASDAQ:NRXP - TradingView
Enterprise value to EBIT forward of NRX Pharmaceuticals, Inc. – NASDAQ:NRXP - TradingView
Enterprise value to EBIT forward of NRX Pharmaceuticals, Inc. – DUS:B1Q - TradingView
Price to earnings forward of NRX Pharmaceuticals, Inc. – DUS:B1Q - TradingView
NRX Pharmaceuticals(NRXP) Stock Options Chain | Quotes & News - Moomoo
H.C. Wainwright Keeps Their Buy Rating on NRX Pharmaceuticals (NRXP) - The Globe and Mail
NRx Pharmaceuticals Subsidiary HOPE Therapeutics Treats First Patients Using Zeta Surgical's FDA-Cleared Zeta TMS Navigation System - marketscreener.com
symbol__ Stock Quote Price and Forecast - CNN
NRX Pharmaceuticals, Inc. Actuals & Estimates (NASDAQ:NRXP) - TradingView
NRx Pharmaceuticals responds to Kadima dispute claims - Investing.com UK
NRx Pharmaceuticals responds to Kadima dispute claims By Investing.com - Investing.com South Africa
NRXP Stock Price, Quote & Chart - ChartMill
NRx Pharmaceuticals Responds to Recent Public Statements Regarding Kadima Dispute - GlobeNewswire
NRx subsidiary begins AI-guided TMS treatments in Florida - Investing.com UK
NRx Pharmaceuticals (Nasdaq: NRXP) Subsidiary HOPE - GlobeNewswire
Kadima sues NRx Pharmaceuticals over failed acquisition deal - Investing.com UK
Kadima Neuropsychiatry Institute Sues NRX Pharmaceuticals Over Breach of Acquisition Contract - marketscreener.com
Kadima sues NRx Pharmaceuticals over failed acquisition deal By Investing.com - Investing.com South Africa
Kadima Neuropsychiatry Institute Files Suit Against NRx Pharmaceuticals (NASDAQ: NRXP), Alleging Breach of Contract and Misrepresentation in Connection with Acquisition - Business Wire
NRx Pharmaceuticals, Inc. (NRXP) reports Q1 loss, lags revenue estimates - MSN
ZETA SURGICAL® Announces Successful Treatment of First Patient with Zeta TMS Navigation System at HOPE Therapeutics - Sahm
BTIG Maintains NRX Pharmaceuticals(NRXP.US) With Buy Rating, Maintains Target Price $25 - Moomoo
EBIT per share of NRX Pharmaceuticals, Inc. – DUS:B1Q - TradingView
Cash per share of NRX Pharmaceuticals, Inc. – DUS:B1Q - TradingView
Tangible book value per share of NRX Pharmaceuticals, Inc. – DUS:B1Q - TradingView
Total common shares outstanding of NRX Pharmaceuticals, Inc. – DUS:B1Q - TradingView
Operating income of NRX Pharmaceuticals, Inc. – DUS:B1Q - TradingView
Net income before discontinued operations of NRX Pharmaceuticals, Inc. – DUS:B1Q - TradingView
NRX Pharmaceuticals, Inc. Income Statement – DUS:B1Q - TradingView
NRX Pharmaceuticals, Inc. Balance Sheet – DUS:B1Q - TradingView
NRX Pharmaceuticals' Hope Therapeutics, Zeta Surgical Treat First Patient With Zeta TMS Navigation System - marketscreener.com
NRx-backed clinic begins guided brain therapy at two Florida sites - Stock Titan
NRX Pharmaceuticals Inc (NRXPW) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey
NRx Pharmaceuticals Announces FDA Grant of Expanded Access Protocol for Use of D-Cycloserine-based NRX-101 for Augmentation of Transcranial Magnetic Stimulation in the Treatment of Depression - Investing News Network
NRx Pharmaceuticals gets FDA approval for NRX-101 protocol - grafa.com
NRx Pharmaceuticals Receives Expanded Access Approval for Experimental Depression Treatment - marketscreener.com
FDA lets NRx offer NRX-101 with TMS for severe depression - Stock Titan
NRX Pharmaceuticals Inc (NRXPW) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey
NRX Pharmaceuticals Inc (NRXPW) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey
NRX Pharmaceuticals Inc (NRXP) Institutional Confidence - TradingKey
1.95%
2.70%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):